Listen to experienced IP professionals discuss how best to right size your IP spending to strike the right balance between reducing IP costs and building your company’s IP position and technology value. This panel will also discuss how the changing IP regulatory environment may impact these decisions.
Moderator: Steven A. Moore
Panelists:
Dr. Bernard (Bernie) Greenspan, Principal, Greenspan IP Management
William A. Lofft, Chief Executive Officer, ZuumCraft, Inc.
Dr. Michael White, Senior Director of the Office of Technology Management & Development, Salk Institute for Biological Studies
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.